【结 构 式】 |
【药物名称】 【化学名称】5-Chloro-N4-(cyclopropylmethyl)-N6-(2,6-dichloro-4-iodophenyl)-2-methyl-N4-propylpyrimidine-4,6-diamine 【CA登记号】 【 分 子 式 】C18H20Cl3IN4 【 分 子 量 】525.6503 |
【开发单位】National Institute on Drug Abuse (Originator), National Institutes of Health (Originator) 【药理作用】DIAGNOSTIC AGENTS, Drugs Acting on Corticotropin-Releasing Factor (CRF) Receptors |
合成路线1
Condensation between 4,6-dichloro-2-methylpyrimidine (I) and 2,6-dichloro-4-iodoaniline (II) in the presence of NaH in THF furnished the diaryl amine (III). The remaining chlorine atom was displaced with N-(cyclopropylmethyl)propylamine (IV) in hot DMSO to yield (V). Finally, chlorination of the pyrimidine ring with N-chlorosuccinimide (NCS) afforded the target 4-iodo derivative.
【1】 Hsin, L.-W.; Webster, E.L.; Tian, X.; et al.; The development of a potential single photon emission computed tomography (SPECT) imaging agent for the corticotropin-releasing hormone receptor type 1. Bioorg Med Chem Lett 2001, 11, 3, 331. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 32323 | 4,6-dichloro-2-methylpyrimidine | 1780-26-3 | C5H4Cl2N2 | 详情 | 详情 |
(II) | 51390 | 2,6-dichloro-4-iodophenylamine; 2,6-dichloro-4-iodoaniline | C6H4Cl2IN | 详情 | 详情 | |
(III) | 51391 | N-(6-chloro-2-methyl-4-pyrimidinyl)-N-(2,6-dichloro-4-iodophenyl)amine; 6-chloro-N-(2,6-dichloro-4-iodophenyl)-2-methyl-4-pyrimidinamine | C11H7Cl3IN3 | 详情 | 详情 | |
(IV) | 27745 | N-(cyclopropylmethyl)-1-propanamine | 26389-60-6 | C7H15N | 详情 | 详情 |
(V) | 51392 | N-(cyclopropylmethyl)-N-[6-(2,6-dichloro-4-iodoanilino)-2-methyl-4-pyrimidinyl]-N-propylamine; N(4)-(cyclopropylmethyl)-N(6)-(2,6-dichloro-4-iodophenyl)-2-methyl-N(4)-propyl-4,6-pyrimidinediamine | C18H21Cl2IN4 | 详情 | 详情 |
Extended Information